Resources

Upcoming Events

EuroTox 2025

September 14-17, 2025 | Athens, Greece

Booth: A10

We’re thrilled to be exhibiting at EUROTOX 2025 Congress in Athens, Greece from September 14-17, 2025. Stop by Booth A10 to connect with toxicology experts Eda Rogers, PhD and Jamin Willoughby, Sr., PhD to discover how our portfolio of primary cells, biospecimens, and human-relevant NAMs can help you meet regulatory requirements and advance your toxicology research.

Schedule a meeting with us!

Join us at our scientific presentations:

LifeNet Health LifeSciences will present new data on its 3D human thyroid microtissue model, showcasing how this first-of-its-kind system links molecular initiating events to phenotypic thyroid hormone disruption in a highly relevant human model.

Poster presentation: “A Human 3D Thyroid Microtissue Model for the Identification of Endocrine Disrupting Compounds”

Dr. Jamin Willoughby will examine key molecular events and distinct response profiles following exposure to various reference compounds, highlighting how the platform differentiates modes of action and supports mechanistic prediction.

Presenter: Jamin A. Willoughby, Sr., PhD

Date/Time: Tuesday, September 16, 2025, 3:30 – 4:00 PM

Session: Poster Viewing III (PV03)

Location: Exhibition and Poster Area; Session Rooms

Poster #: P30-46

Oral presentation: “Evaluation of an In Vitro Thyroid Microtissue Assay for Screening Thyroid Disruptive Chemicals”

Dr. Eda Rogers will incorporate and expand upon the poster findings, demonstrating the reproducibility, reliability, and utility of the model for high-throughput, multi-mechanistic screening of thyroid disrupting chemicals.

Presenter: Eda Rogers, PhD

Date: Monday, September 15, 2025

Session: Short Orals Session (OS01)

Location: Room 4

Presentation: OS01-12 (5:50 - 6:00 PM)

Meet Our Experts!

Tuesday, September 16th from 1:00 – 2:00 pm

Our experts will be available at Booth A10 to discuss how our solutions are designed to advance toxicology research.

ISSX 2025

September 21-24, 2025 | Chicago, Illinois

Past Events

Microphysiological Systems (MPS) World Summit 2025

The 21st Annual Congress of International Drug Discovery Science and Technology (IDDST)

LifeNet Health expands primary human liver cell offering

LifeNet Health strengthens its LifeSciences Division with Samsara Sciences asset acquisition

November 07, 2019

Virginia Beach, VA. - LifeNet Health, the world's leading provider of regenerative medicine solutions, has acquired the assets of Samsara Sciences, a San Diego-based life sciences company specializing in human primary liver and kidney cell isolation. The acquisition includes Samsara's equipment, inventory and associated technology.

New Center of Excellence for research in San Diego

LifeNet Health unveils Center of Excellence for research in San Diego

May 14, 2019

SAN DIEGO, Calif. - May 14, 2019 - LifeNet Health, the world’s leading provider of regenerative medicine solutions, today announced the opening of a San Diego facility that stands as a Center of Excellence for its life sciences and tissue-engineering programs, as well as a logistical hub for hospital and surgeon clients on the West Coast.

LifeNet Health expands regenerative medicine efforts with opening of Research Triangle Park, N.C., facility

November 03, 2016

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health is expanding its cell-based research and processing capacity with the opening of a facility in North Carolina’s Research Triangle Park (RTP), near Durham. It will be an extension of its flagship research center, the LifeNet Health Institute of Regenerative Medicine, located at the company’s headquarters in Virginia Beach, Va.

LifeNet Health announces new advances technology platforms with acquisition of Vivo Biosciences, Inc., assets

November 2, 2016

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health has acquired the assets of Alabama-based biotechnology company Vivo Biosciences, Inc., as part of the organization’s growing emphasis on applying cell-based innovations to the process of pharmaceutical discovery and personalized medicine.